NL8503413A - Preparaten ter bestrijding van diarrhee. - Google Patents

Preparaten ter bestrijding van diarrhee. Download PDF

Info

Publication number
NL8503413A
NL8503413A NL8503413A NL8503413A NL8503413A NL 8503413 A NL8503413 A NL 8503413A NL 8503413 A NL8503413 A NL 8503413A NL 8503413 A NL8503413 A NL 8503413A NL 8503413 A NL8503413 A NL 8503413A
Authority
NL
Netherlands
Prior art keywords
substances
phenylalanine
preparation according
adhesin
isoleucine
Prior art date
Application number
NL8503413A
Other languages
English (en)
Dutch (nl)
Original Assignee
Vereniging Voor Christelijk Wetenschappelijk Onderwijs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vereniging Voor Christelijk Wetenschappelijk Onderwijs filed Critical Vereniging Voor Christelijk Wetenschappelijk Onderwijs
Priority to NL8503413A priority Critical patent/NL8503413A/nl
Priority to EP19860906963 priority patent/EP0248838A1/en
Priority to PCT/NL1986/000041 priority patent/WO1987003485A1/en
Priority to JP50002387A priority patent/JPS63501950A/ja
Publication of NL8503413A publication Critical patent/NL8503413A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NL8503413A 1985-12-11 1985-12-11 Preparaten ter bestrijding van diarrhee. NL8503413A (nl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
NL8503413A NL8503413A (nl) 1985-12-11 1985-12-11 Preparaten ter bestrijding van diarrhee.
EP19860906963 EP0248838A1 (en) 1985-12-11 1986-12-09 Compositions for combatting diarrhoea
PCT/NL1986/000041 WO1987003485A1 (en) 1985-12-11 1986-12-09 Compositions for combatting diarrhoea
JP50002387A JPS63501950A (ja) 1985-12-11 1986-12-09 下痢治療用組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8503413 1985-12-11
NL8503413A NL8503413A (nl) 1985-12-11 1985-12-11 Preparaten ter bestrijding van diarrhee.

Publications (1)

Publication Number Publication Date
NL8503413A true NL8503413A (nl) 1987-07-01

Family

ID=19847002

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8503413A NL8503413A (nl) 1985-12-11 1985-12-11 Preparaten ter bestrijding van diarrhee.

Country Status (4)

Country Link
EP (1) EP0248838A1 (ja)
JP (1) JPS63501950A (ja)
NL (1) NL8503413A (ja)
WO (1) WO1987003485A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK53291D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
US6818585B2 (en) * 1998-12-30 2004-11-16 Univation Technologies, Llc Catalyst compounds, catalyst systems thereof and their use in a polymerization process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU76538A1 (ja) * 1977-01-07 1978-09-18
SU921712A1 (ru) * 1979-12-10 1982-04-23 Ереванский политехнический институт им.К.Маркса Станок дл обработки шатунных шеек коленчатых валов
DE3213740A1 (de) * 1982-04-14 1983-12-15 Oerlikon-Boehringer GmbH, 7320 Göppingen Wirbelgeraet
JPS591101A (ja) * 1982-05-24 1984-01-06 Komatsu Ltd クランクシヤフトミラ−

Also Published As

Publication number Publication date
EP0248838A1 (en) 1987-12-16
JPS63501950A (ja) 1988-08-04
WO1987003485A1 (en) 1987-06-18

Similar Documents

Publication Publication Date Title
Svennerholm et al. Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea
Yokoyama et al. Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets
Bowersock et al. Oral vaccination with alginate microsphere systems
Xu et al. Application of chicken egg yolk immunoglobulins in the control of terrestrial and aquatic animal diseases: a review
Reiter Antimicrobial systems in milk
Van den Broeck et al. Induction of immune responses in pigs following oral administration of purified F4 fimbriae
CA2782639C (en) Therapies for preventing or suppressing clostridium difficile infection
Gadde et al. Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases–a review
Deneke et al. Attachment pili from enterotoxigenic Escherichia coli pathogenic for humans
Alustiza et al. IgY against enterotoxigenic Escherichia coli administered by hydrogel-carbon nanotubes composites to prevent neonatal diarrhoea in experimentally challenged piglets
Newby Protective immune responses in the intestinal tract
Al-Adwani et al. Production and evaluation of chicken egg-yolk-derived antibodies against Campylobacter jejuni colonization-associated proteins
WO2017068112A1 (en) Immunogenic fusion protein
Barati et al. Production of chicken egg yolk antibody (IgY) against recombinant cholera toxin B subunit and evaluation of its prophylaxis potency in mice
Isfahani et al. The effect of capsulated and noncapsulated egg-yolk–specific antibody to reduce colonization in the intestine of Salmonella enterica ssp. enterica serovar Infantis–challenged broiler chickens
NL8503413A (nl) Preparaten ter bestrijding van diarrhee.
Cometta et al. Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients.
Lee et al. Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice
Strindelius et al. Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice
JP2006504619A (ja) 標的因子の特異的食作用のための多機能複合体
EP0873755A1 (en) Prevention and treatment of enterohemorrhagic E. coli infection
KR100267746B1 (ko) 돼지 대장균 설사증 예방 및 치료용 난황항체를 이용한 경구용 면역제제
Stern et al. Potentials for colonization control of Campylobacter jejuni in the chicken
US20240173394A1 (en) Immunogenic fusion protein
Majumder et al. Egg Yolk Antibody Farming for Passive Immunotherapy

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed